How Merck aids lateral flow test development
From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market
From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new products which have made the most difference to clinical diagnostics
Visit our new Accelerating Science Feature to explore the remarkable achievements in the fields of PFAS, battery testing, and beyond
This month’s webinar explores digitization and context in full-field morphological hematology
Available on Demand
New automations in liquid biopsy research hold great promise for bringing us even closer to fully realizing its clinical utility in monitoring cancer from diagnosis through to remission
Learn how CDD’s AI search tool offers a rapid and secure means to discover and optimize promising drug candidates
On July 3, SelectScience and ELRIG will be hosting an online event showcasing advances in cell-based screening in drug discovery to extend high-quality content to the global audience
Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department
Explore the modern point-of-care ecosystem and its impact on healthcare delivery
Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring
This guest editorial explores how regenerative agriculture can solve current farming challenges, and how soil health may be the answer under our feet
Learn about the different types of battery testing and explore additional considerations for optimizing performance
Demonstrating ongoing commitment to providing a secure data environment for customers
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
Learn how the latest automated cell counting technology is enhancing autoimmune disease research at Yale School of Medicine’s Hafler Lab
Agilent Technologies, Merck, ZEISS, and Waters among those recognized
Dr. Kangxin He at Zhejiang University has developed a high-throughput drug screening platform using patient-derived organoids to identify the best treatment for individual patients
Top tips to increase open and click rates and achieve quality ROI
Discover opportunities to engage with and grow your audience
Microstructural ‘fingerprints’ of inhalation powders revealed by AI image analysis could help scientists develop better treatments for asthma